Arvinas (ARVN) Assets (2017 - 2026)
Arvinas (ARVN) recorded Assets of $675.1 million in Q2 2026, down 25.8% from $909.3 million a year earlier but up 4.3% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Arvinas reported Assets of $717.9 million, down 34.2% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- Across earlier years, Assets came in at $1.09 billion in FY2024 (-16.3%), $1.3 billion in FY2023 (+2.8%), $1.27 billion in FY2022 (-19.8%) and $1.58 billion in FY2021 (+120.5%).
- Quarterly Assets has ranged from $647.5 million in Q1 2026 to $1.6 billion in Q3 2021 over the past five years.
- On a year-over-year basis, Assets has declined for seven consecutive quarters, with an average decline of 21.9% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 490.1% in Q3 2021, against a decline of 35.3% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $647.5 million (Q1 2026), $717.9 million (Q4 2025) and $844.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.23 Bn | 1,138.82 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 648.85 Bn | 568.71 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 504.91 Bn | 478.02 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 268.65 Bn | 242.33 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 242.96 Bn | 198.36 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 173.22 Bn | 119.87 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Arvinas | 498.64 Mn | -2.16 Bn | - | 675.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 675.10 Mn |
| Mar 31, 2026 | 647.50 Mn |
| Dec 31, 2025 | 717.90 Mn |
| Sep 30, 2025 | 844.30 Mn |
| Jun 30, 2025 | 909.30 Mn |
| Mar 31, 2025 | 1.00 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.17 Bn |
| Jun 30, 2024 | 1.28 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.30 Bn |
| Sep 30, 2023 | 1.06 Bn |
| Jun 30, 2023 | 1.08 Bn |
| Mar 31, 2023 | 1.18 Bn |
| Dec 31, 2022 | 1.27 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.41 Bn |
| Mar 31, 2022 | 1.49 Bn |
| Dec 31, 2021 | 1.58 Bn |
| Sep 30, 2021 | 1.60 Bn |
API Access
Arvinas Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();